Published on : Nov 03, 2017
Albany, New York, November 3, 2017: The global IVF market is likely to witness steady growth during the forecast period 2017-2022 on account of rising infertility among couples. High success ratio of IVF process, along with greater awareness among couples is a key factor that is boosting the adoption of IVF. Further, there is a significant decline in the taboo status of infertility in many developing countries, which has led more couples to undergo counselling and eventually seek treatment. These factors are likely to boost the global in-vitro fertilization market during the forecast period. These insights are according to a recent research report added to the repository of Market Research Hub (MRH). The report titled “In-Vitro Fertilization Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022” offers comprehensive analysis on the global IVF market during the forecast period.
The global in-vitro fertilization market is likely to grow at a CAGR of over 6% to surpass US$ 700 Mn by the end of 2022. North America is likely to remain an important market due to the focus on R&D, and also on account of positive perception about IVF among patients. However, it will be the market in APEJ that will remain central to the prospects of IVF market during the forecast period. There are many overt and subtle reasons for the projected rise in demand for in-vitro fertilization market during the forecast period.
Unlike in developed regions, the decision to have a baby is enforced by social and cultural factors. Many infertile couples are under high pressure from their families to have a child owing to which in-vitro fertilization has emerged as a credible option. Considering the high population that calls APEJ home, it is highly likely that in-vitro fertilization market players will have substantial growth opportunities during the forecast period.
By product type, the key segments in the global in-vitro fertilization market include reagents and equipment. Currently, the demand for reagents is higher than that of equipment. Reagents account for over half the revenue share of the market, and it is highly likely that they will continue to lead in terms of revenue share.
Leading players profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., Vitrolife AB, Genea Ltd., EMD Serono, Inc., CooperSurgical, Cook Medical, Rocket Medical PLC, Ovascience, Inc., and Fertility Focus Ltd. These players are focusing on consolidating their position in APEJ market, which is likely to lead to mergers and acquisitions during the forecast period.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1359774
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com